Loading company…
Minerva Surgical develops devices to treat abnormal uterine bleeding.
Founded in 2008 and based in Santa Clara, US, Minerva Surgical develops devices to treat abnormal uterine bleeding. Its products include Minerva ES, Symphion, Genesys HTA, and Resectr, intended for premenopausal women who have completed childbearing. The company raised USD 16.72 million in December 2016 and began trading on the Nasdaq Global Market as UTRS in October 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in